UTHR
UNITED THERAPEUTICS Corp · Healthcare · Market cap $24.2B
Insiders sold $180.7M net in the last 90 days ·3 sellers, 0 buyers· 38 of 39 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 22, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$180.7M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Oct 22, 2026
ROTHBLATT MARTINE A
UNITED THERAPEUTICS Corp (UTHR) has 40 SEC Form 4 filings (500 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Oct 22, 2026.
Inside the rolling window, 3 insiders at UNITED THERAPEUTICS Corp reported no open-market purchases and 39 open-market sales totaling $180.7M. The most active filer is Chairperson & CEO ROTHBLATT MARTINE A with 35 filings. Insiders have net sold $180.7M over the trailing 6 months. The most recent open-market filing is a sale of 9,500 shares by Chairperson & CEO ROTHBLATT MARTINE A, dated Oct 21, 2026, worth $5.3M.
- Industry:Biotechnology
- CEO:Martine A. Rothblatt
- Employees:1,400
- HQ:Silver Spring, MD, US
- IPO:1999-06-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chairperson & CEO | Sale | 9,500 | $5.3M | Oct 22 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Oct 21 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 20 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Oct 19 | — | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.5M | Oct 16 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 16 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Oct 15 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 14 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 13 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 13 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Oct 9 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 8 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Oct 7 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Oct 6 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Oct 5 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | Oct 2 | — | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.7M | Oct 1 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Oct 1 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.5M | Sep 30 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.6M | Sep 29 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.5M | Sep 28 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.5M | Sep 25 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.7M | Sep 24 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.7M | Sep 23 | — | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.7M | Sep 22 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading UTHR 8 all-time
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-11
- RRep. Michael T. McCaulSale$15,001 - $50,0002023-05-12
- RRep. Michael T. McCaulSale$100,001 - $250,0002023-05-12
- RRep. Michael T. McCaulPurchase$15,001 - $50,0002022-03-01
- RRep. Michael T. McCaulPurchase$1,001 - $15,0002022-03-01
- RRep. Michael T. McCaulSale$1,001 - $15,0002022-01-28
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does UTHR have?
UNITED THERAPEUTICS Corp (UTHR) has 40 SEC Form 4 filings (500 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Oct 22, 2026.
When was the most recent SEC Form 4 filing for UTHR?
The most recent Form 4 filing for UTHR on Tracefour is dated Oct 22, 2026.
Who is the most active insider at UTHR?
The most active SEC Form 4 filer at UTHR in the rolling window is Chairperson & CEO ROTHBLATT MARTINE A, with 35 filings.
What is the net insider flow at UTHR over the last 6 months?
Over the trailing 180 days, insiders at UTHR have net sold $180.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at UTHR in the current window?
Inside the rolling window, insiders at UTHR bought $0 and sold $180.7M based on SEC Form 4 filings.
Can I get alerts for UTHR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at UNITED THERAPEUTICS Corp (UTHR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
UNITED THERAPEUTICS Corp is in the Healthcare sector.